Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05605873

Clinical, Histological and Prognostic Forms of Adenocarcinoma of the Anus

Conditions: Anal Adenocarcinoma

Sex: All
Ages: 18 Years – N/A
Enrollment: 46
Sponsor: Groupe Hospitalier Paris Saint Joseph

Location: France

Summary

Adenocarcinoma of the anus is rare. It concerns less than 10% of anal cancers and its incidence is less than 0.2/100 000 inhabitants. Its management is not consensual and is most often derived by analogy with that of adenocarcinoma of the lower rectum. This is due to the rarity but also to the diversity of anatomical (anal margin, anal canal, lower rectum), etiological (primary glandular tumors or secondary to anal fistula, primary distant tumor and/or Crohn's disease) and histological forms (mucinous, intestinal, glandular adenocarcinomas and primary or secondary Paget's disease). Most of the literature consists of small case series and simple clinical cases in which the prognosis of these subforms has not been studied.

Eligibility Criteria

Inclusion Criteria:Patient over 18 years of ageFrench-speaking patientPatient with a diagnosis of adenocarcinoma of the anus between 01/01/2006 and 30/06/2022 in participating centersExclusion Criteria:Patient under guardianship or curatorshipPatient deprived of libertyPatient under court protectionPatient objecting to the use of his data for this research

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05605873). StuddyBuddy aggregates publicly available trial information.